genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Illumina
Drug Discovery
StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug
New Products
Enzyme-Detection Kit
Insights
Inexpensive Sequencing Is Enabling the Age of Multiomics
A-Lists
Top 25 Biotech Companies of 2024
Insights
What Will 2024 Mean for NGS and Genomics?
Artificial Intelligence
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
GEN Edge
JPM: Illumina’s New CEO Spells Out 2024 Priorities, Presents Preliminary Q4, 2023 Results
Artificial Intelligence
Leveraging Genomic AI to Deliver a More Accurate and Comprehensive Genome
GEN Edge
StockWatch: Illumina Shares Climb Back after Tailspin from Q3 Results
News
Illumina to Divest of Grail after Appeals Court Defeat
1
2
3
4
...
9
Page 3 of 9
Scroll Up
Scroll Up
